Following the ASH 2022 Annual Meeting, hematologic oncology experts discuss updated data in acute lymphocytic leukemia.
Leukemia: A Review of Data from the ASH 2022 Meeting
Experts in hematologic oncology review and analyze updated data in chronic myeloid leukemia from ASH 2022.
Shared insight on recently updated data in acute myeloid leukemia following the ASH 2022 annual meeting.
Advertisement
Advertisement
Trending on OncLive
1
Managing Long-Term Toxicities and Emerging Therapies in ALK-Positive NSCLC
2
Five Under 5: Top Oncology Videos for the Week of 6/28
3
The OncFive: Top Oncology Articles for the Week of 6/28
4
Divesiran Reduces Phlebotomy Burden and Improves Iron Stores in Polycythemia Vera
5